EntrePRECISIONeur

Abstract

Inside Precision MedicineVol. 10, No. 3 InterviewsEntrePRECISIONeurUsing the Epigenome to Guide Development of Gene Edited TherapiesHelen AlbertHelen AlbertHelen Albert is senior editor at Inside Precision Medicine and a freelance science journalist. Prior to going freelance, she was editor-in-chief at Labiotech, an English-language, digital publication based in Berlin focusing on the European biotech industry. Before moving to Germany, she worked at a range of different science and health-focused publications in London. She was editor of The Biochemist magazine and blog, but also worked as a senior reporter at Springer Nature's medwireNews for a number of years, as well as freelancing for various international publications. She has written for New Scientist, Chemistry World, Biodesigned, The BMJ, Forbes, Science Business, Cosmos magazine, and GEN. Helen has academic degrees in genetics and anthropology, and also spent some time early in her career working at the Sanger Institute in Cambridge before deciding to move into journalism.Senior EditorSearch for more papers by this authorPublished Online:7 Jun 2023https://doi.org/10.1089/ipm.10.03.10AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 10Issue 3Jun 2023 InformationCopyright © GEN PublishingTo cite this article:Helen Albert.EntrePRECISIONeur.Inside Precision Medicine.Jun 2023.36-38.http://doi.org/10.1089/ipm.10.03.10Published in Volume: 10 Issue 3: June 7, 2023PDF download